- TheStreet.com•8 hours ago
While companies in the opiod sector have had to deal with headlines about abuse as well as pharma pricing controversies, Depomed reported increased sales across its product line.
- Associated Press•12 hours ago
On a per-share basis, the Newark, California-based company said it had a loss of 72 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to 48 cents per share. The results topped ...
- GlobeNewswire•13 hours ago
-Record Annual Revenue of $456 million in 2016-. -Record Quarterly Revenue of $124 million in Fourth Quarter–. -Conference Call Scheduled for Today at 4:30 PM EST; Dial-In Information Below-.
DEPO : Summary for Depomed, Inc. - Yahoo Finance
Depomed, Inc. (DEPO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||16.06 x 400|
|Ask||16.99 x 200|
|Day's Range||15.64 - 16.60|
|52 Week Range||12.25 - 27.02|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-12.82|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|